Great Email Reply back from CXM IR!!!
This was an email reply back to a member on yahoo finance, it was asking Bonnie in IR some great questions concerning CXM!! Sounds good to me, this month may be BIG!!!
Hello Bonnie, a few questions for you!
1. Why is Excellagen still not available on the Excellagen website while we are attending "these" conferences? As we have previously reported, Excellagen is expected during first quarter ending March 31, 2012. Since Excellagen is expected shortly the local DFCON meeting being held in Los Angeles provides us with a pre-marketing opportunity.
2.
2. If Cardium is attending these conferences to educate health care providers on Excellagen, shouldn't Excellagen be accessible immediately for doctors to purchase? As I mentioned above, the DFCON meeting is a pre-marketing opportunity and interested physicians from the meeting will be contacted when product Excellagen is available.
3. What kind of Excellagen "education" for doctors is taking place at these conferences? We have a display booth with Cardium representatives in attendance to discuss Excellagen with attending physicians who visit our booth.
4. Can you define "Excellagen Launch" for me in Cardium Therapeutics terms? The initial distribution platform will include a cold-chain distribution capability to facilitate the supply of product to physicians, educating physicians and wound care clinics about Excellagen through mass mailings, promotions, advertising in trade publications, presenting and exhibiting at medical trade shows, web outreach to both physicians and patients, website physician locator, building a network of key opinion leaders, and other sales and marketing programs. Consistent with our business strategy, we have no plans to establish an internal direct sales force and will look to strategic partners in the U.S., as well as internationally. In line with this strategy, we recently announced an agreement for the sale and distribution of Excellagen in Korea, which represents the first of what we plan to be a series of marking and distribution agreements with commercialization partners.
5. While Cardium considers "launching" Excellagen into the market is by attending these conferences, when can we assume that actual sales will begin? As previously reported and as I mentioned above, Excellagen is expected to be launched in first quarter ending March 31, 2012. We are completing final logistics and expect to meet our target.
AI
